Welcome to our dedicated page for Xos SEC filings (Ticker: XOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xos, Inc. filings document the public-company record for an electric commercial vehicle and fleet electrification business. Recent Form 8-K reports disclose operating results and financial condition, material agreements, equity financing arrangements, convertible promissory note amendments, facility lease matters, and changes in board composition.
The company's proxy materials describe annual meeting governance, director matters, executive compensation, equity awards, and pay-versus-performance information. Other disclosures identify its Nasdaq-listed common stock and warrants, share issuance limits, at-the-market common stock sales, and exhibits tied to contracts and press releases.
Xos, Inc. is registering up to $100,000,000 of securities on a shelf basis. This shelf prospectus permits the company to offer, from time to time, Common Stock, Preferred Stock, Debt Securities, Warrants and Units in any combination, up to an aggregate amount of $100,000,000, with specific terms to be provided in prospectus supplements.
As context, the filing states that as of June 5, 2026
8,037,156 shares of Common Stock were held by non-affiliates, representing an aggregate market value of $59,957,184 based on a reported sale price of $7.46 per share on June 3, 2026working capital and general corporate purposes, and distribution methods to be set forth in supplements.
Xos, Inc. entered into securities purchase and placement agency agreements for a registered direct offering of 1,090,910 shares of common stock at $5.50 per share. The company closed the transaction shortly after signing.
The offering generated approximately $6.0 million in gross proceeds before fees and expenses. Roth Capital Partners, LLC acted as exclusive placement agent and will receive a 6.5% cash fee on gross proceeds plus reimbursement of up to $75,000 of expenses.
Xos, Inc. files a prospectus supplement updating its at-the-market sales capacity under a Sales Agreement with Roth Capital Partners to up to $8,618,796 of common stock. The supplement cites a public float of $59,957,184 based on 8,037,156 shares outstanding as of June 5, 2026 and a prior 12-month issuance of $11,366,932 under the same Form S-3 instruction. The Sales Agreement pays Roth Capital Partners a 3.0% fee on aggregate gross proceeds. The prospectus supplement modifies the ATM Prospectus Supplement and Base Prospectus and is qualified by them.
Emerald Green Trust, a major shareholder of Xos, Inc., reported open-market sales totaling 400,000 shares of common stock over June 3–4, 2026. Reported sale prices ranged from about $4.52 to $6.52, with weighted average prices of $6.4602, $5.9697, $5.7794, and $5.0296 for the individual trades. Following these transactions, the trust held 1,241,269 shares of Xos common stock. A footnote states the sales were executed under a pre-arranged Rule 10b5-1 trading plan established on November 21, 2025, and that after the June 4 trades the trust ceased to be a beneficial owner of 10% or more of Xos’s outstanding common stock, so it is no longer subject to Section 16 reporting.
Xos, Inc. is offering 1,090,910 shares of its common stock at an offering price of $5.50 per share pursuant to this prospectus supplement. The offering's aggregate public offering price is $6,000,005 with placement agent fees of $390,000 (6.5%). After placement agent fees and estimated offering expenses, estimated net proceeds to Xos are approximately $5.4 million. The prospectus states the offering will be conducted on a reasonable "best efforts" basis through Roth Capital Partners, LLC as exclusive placement agent and notes Nasdaq listing under the symbol XOS. Shares outstanding were 12,567,531 as of June 3, 2026 and are projected to be 13,658,441 after this Offering.
Xos, Inc. Chief Executive Officer and director Dakota Semler reported a bona fide gift of 30,000 shares of Common Stock. The transfer was a gift to several persons who are not immediate family members and did not involve a sale or purchase in the market.
After the gift, Semler holds 847,061 shares of Xos common stock directly, which include 499,430 unvested restricted stock units (RSUs). This filing mainly updates Semler’s reported ownership and reflects a non-cash, non-market disposition.
Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 4,921 shares of Common Stock on May 20, 2026 at a weighted average price of $2.0006 per share, with trades ranging from $2.00 to $2.0015.
After the sale, he directly holds 88,058 shares, which include 62,377 unvested RSUs, and indirectly holds 4,133 shares through Bernstein Investment Partners LLC, where he is the Managing Member. The sale represents a relatively small portion of his overall direct holdings.
Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 5,179 shares of Common Stock on March 31, 2026 at a weighted average price of about $1.6418 per share. Following the sale, he holds 92,979 shares directly, which include 62,377 unvested RSUs, and 4,133 shares indirectly through Bernstein Investment Partners LLC.
Xos, Inc. submitted a Form 144 reporting an intended sale of 1,842.00 shares of common stock. The filing also lists recent dispositions of 1,108 shares on 03/31/2026 and 4,071 shares on 04/02/2026 as sales in the prior three months.